• Activity INFORMATION

  Overview

  The use of biologics to treat cancer and autoimmune diseases like lupus, rheumatoid arthritis, and multiple sclerosis has increased as research and technology have advanced over the last several decades. These biologic medicines take advantage of the immune system to either enhance or block its action depending on the condition being treated. It is important for healthcare providers to have a basic understanding of the normal adaptive immune response to understand the mechanism of action and side effects of these drugs. This issue of The Rx Consultant will provide a background on the development, regulation, and naming of biologic drugs, an overview of adaptive immunity, a discussion on drug classes that modulate the immune response, and considerations before and during treatment with immunomodulating biologics.
  

  Handouts

  • Homestudy PDF :   22111H01.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize the key differences between biologics and biosimilars and the FDA guidance on the interchangeability of biologics for biosimilars.

  Recall the history of the development of biologics.

  Identify the most common disease conditions in which biologics are used, biologics used, and their mechanisms of action in those disease states.

  List the common and severe adverse effects, precautions, contraindications, black box warnings, and testing considerations associated with biologics.

  Nurse

  Identify the most common disease conditions in which biologics are used, biologics used, and their mechanisms of action in those disease states.

  Recognize the key differences between biologics and biosimilars and the FDA guidance on the interchangeability of biologics for biosimilars.

  List the common and severe adverse effects, precautions, contraindications, black box warnings, and testing considerations associated with biologics.

  Recall the history of the development of biologics.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-901890

  Universal Activity Number

  Pharmacist 0798-0000-22-111-H01-P
  Nurse 0798-0000-22-111-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Olajumoke  Amuwo, PharmD, MPH, BCPS Assistant Professor of Clinical Sciences, Roosevelt University College of Health and Sciences and Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).